High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2015, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2015-06-08
DOI
10.1155/2015/178513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
- (2015) Gustav Holmgren et al. TOXICOLOGY
- Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
- (2015) Luc Rochette et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold
- (2014) Mohd Rashid et al. Anti-Cancer Agents in Medicinal Chemistry
- Protective Role of Naringenin Against Doxorubicin-Induced Cardiotoxicity in a Rat Model: Histopathology and mRNA Expression Profile Studies
- (2014) Swathika Subburaman et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective
- (2014) Péter Bencsik et al. PHARMACOLOGICAL RESEARCH
- Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents
- (2013) Hyun Jung Kwak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Doxorubicin-treated H9c2 cells: caution with luminescent ATP and Hoechst 33258 assays
- (2013) Richard J. Calvert et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart
- (2013) Zoltán V. Varga et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II
- (2012) Brian B. Hasinoff et al. BIOCHEMICAL PHARMACOLOGY
- 3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism
- (2012) Petra Lakatos et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- How does doxorubicin work?
- (2012) Anand G Patel et al. eLife
- Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
- (2012) Bray Denard et al. eLife
- Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction
- (2011) Magdolna Szántó et al. CARDIOVASCULAR RESEARCH
- Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation
- (2011) Wei-Tien Chang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro
- (2011) Jing Xiao et al. TOXICOLOGY
- Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors
- (2010) Shadia A. Galal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: Role of nitric oxide
- (2010) Tamás Csont et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats
- (2010) Wawaimuli Arozal et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
- (2009) Partha Mukhopadhyay et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer
- (2008) Roberto Petrioli et al. CANCER TREATMENT REVIEWS
- Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA
- (2008) Meral Tunçbilek et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Thiazolobenzimidazole TBZE-029 Inhibits Enterovirus Replication by Targeting a Short Region Immediately Downstream from Motif C in the Nonstructural Protein 2C
- (2008) A. M. De Palma et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation